comparemela.com

Latest Breaking News On - Treatment cost - Page 6 : comparemela.com

Therapeutics for Women s Health - A Comprehensive Industry Assessment Highlighting the Key Opportunities, Pricing & Reimbursement, Players, and Strategic Recommendations

Swasthya Sathi: Bengal govt increases rates for 33 packages - The Hindu BusinessLine

Swasthya Sathi: Bengal govt increases rates for 33 packages PTI Kolkata | Updated on × The treatment rate of cardiac-related problems was raised by 25 per cent, and those of general medical conditions increased by around 20 per cent. Following requests from private hospitals to revise rates of various treatments under the Swasthya Sathi health insurance scheme, the West Bengal government has decided to enhance rates for at least 33 packages, a senior official said on Tuesday. While rates for treatment of cardiac-related problems were raised by 25 per cent, those for general medical conditions were increased by around 20 per cent, Health Secretary NS Nigam said. The overall expenditure due to the revision will rise by 7-10 per cent, Nigam said.

Worldwide CAR T-Cell Therapy Industry to 2030 - Players Include Legend Biotech, Novartis & Pfizer Among Others

Share this article Share this article ResearchAndMarkets.com s offering. The scientific community has been pursuing research for the development of CAR T-cell therapy for over a century. Immunotherapy has emerged as an innovative treatment option over decades, as it harnesses the patient s immune system to attack cancer. The global market for CAR T-cell therapy is predicted to grow at a CAGR of 44.79% over the forecast period 2020-2030. The market is driven by certain factors, which include increasing global geriatric population, increasing number of lymphoma and leukemia cases, rising number of relapsed or refractory cancer cases showing response failure to alternative treatments such as chemotherapy and radiation therapy, focus on research and development of novel immunotherapies, and strong product pipeline of global CAR T-cell therapy.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.